Abstract:Abstract: Colorectal cancer (CRC) is one of the most common cancers in men and women worldwide as well as is the leading cause of death in the western world. Almost a third of the patients has or will develop liver metastases. While genetic as well as epigenetic mechanisms are important in CRC pathogenesis, the basis of the most cases of cancer is unknown. High spatial and inter-patient variability of the molecular alterations qualifies this cancer in the group of highly heterogeneous tumors, which makes it harder to elucidate the mechanisms underlying CRC progression. Determination of highly sensitive and specific early diagnosis markers and understanding the cellular and molecular mechanism(s) of cancer progression are still a challenge of the current era in oncology of solid tumors. One of the accepted risk factors for CRC development is overexpression of insulin-like growth factor 2 (IGF2), a 7.5-kDa peptide produced by liver and many other tissues. IGF2 is the first gene discovered to be parentally imprinted. Loss of imprinting (LOI) or aberrant imprinting of IGF2 could lead to IGF2 overexpression, increased cell proliferation, and CRC development. IGF2 as a mitogen is associated with increased risk of developing colorectal neoplasia. Higher serum IGF2 concentration as well as its tissue overexpression in CRC compared to control are associated with metastasis. IGF2 protein was one of the three candidates for a selective marker of CRC progression and staging. Recent research indicates dysregulation of different micro- and long non-coding RNAs (miRNAs and lncRNAs, respectively) embedded within the IGF2 gene in CRC carcinogenesis, with some of them indicated as potential diagnostic and prognostic CRC biomarkers. This review systematises the knowledge on the role of genetic and epigenetic instabilities of IGF2 gene, free (active form of IGF2) and IGF-binding protein (IGFBP) bound (inactive form), paracrine/autocrine secretion of IGF2, as well as mechanisms of inducing dysplasia in vitro and tumorigenicity in vivo. We have tried to answer which molecular changes of the IGF2 gene and its regulatory mechanisms have the most significance in initiation, progression (including liver metastasis), prognosis, and potential anti-IGF2 therapy in CRC patients.

Genomic Imprinting of Insulin-Like Growth Factorii in Colorectal Cancer and Its Relationship with the Presence of Metastasis

IGF-II Promotes the Proliferation and Apoptosis of Human Colorectal Adenocarcinomas and Its Clinical Significance

Expression and Clinical Significance of IGF-I and IGF-IR in Colorectal Cancer

Expression of Insulin-Like Growth Factor- II Mrna-Binding Protein 3 in Colon Cancer and Its Implication

[Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].

The Role of Insulin-Like Growth Factor 1 and Its Receptor in the Formation and Development of Colorectal Carcinoma.

[Genomic Imprinting of Insulin-Like Growth Factor II in Prostate Cancer and Its Clinical Significance].

Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer—from Basic Research to Potential Clinical Applications

Overexpression Of Hmga2 Promotes Metastasis And Impacts Survival Of Advanced Colorectal Cancers

Elevated IGFIR Expression Regulating VEGF and VEGF-C Predicts Lymph Node Metastasis in Human Colorectal Cancer.

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas

Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.

Expression Patterns of Insulin-Like Growth Factor 1 (Igf-I) and Its Receptor in Mammary Tissues and Their Associations with Breast Cancer Survival

Expression of insulin-like growth factor-Ⅰ receptor in colorectal polypus and its clinical significance

Up-Regulation of Insulin-Like Growth Factor-2 Promotes Cell Proliferation and Migration and is Associated with Bone Metastasis in Non Small Cell Lung Cancer.

Increased Igf2bp3 Expression Promotes The Aggressive Phenotypes Of Colorectal Cancer Cells In Vitro And Vivo

Progress in the Research of Cancer-related Imprinted Genes

IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy

[Expression of Matrix Metalloproteinase-2 and Insulin-Like Growth Factor-1 in Gastric Carcinoma and Their Clinicopathological Significance].

IGF2 LOI and Expression in CRC Patients

Clinical Implications of Insulin-Like Growth Factor II Mrna-Binding Protein 3 Expression in Non-Small Cell Lung Carcinoma